Article ID Journal Published Year Pages File Type
8227675 International Journal of Radiation Oncology*Biology*Physics 2012 9 Pages PDF
Abstract
At a mean follow-up of 36 months, dose-escalated chemotherapy-IMRT at DL2 has so far been safe to deliver. In this study, DL2 delivered high rates of locoregional control, progression-free survival, and organ preservation and has been selected as the experimental arm in a Cancer Research UK Phase III study.
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Authors
, , , , , , , , , , , , ,